Recent Updates
Recently added Catalysts
NEUP Neutral Sentiment Score: 50/100

Appendix 3Y Change of Director's Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documen

Key Takeaway: Bionomics Limited has submitted a Change of Director's Interest Notice for Dr. Errol De Souza, detailing changes in the director's interests in securities. As of February 23, 2023, Dr. De Souza acquired 10,000,000 unlisted options and disposed of 1,666,667 unlisted options. The notice includes the number of securities held before and after the changes. This submission follows ASX listing rule 3.19A.2, which requires disclosure of changes in a director's interests in a timely manner.

Market Sentiment Analysis

Full Press Release Details

Change of Director's Interest Notice
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Bionomics Limited
ABN 53 075 582 740
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director Dr Errol De Souza
Date of last notice 28 November 2022
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of notifiable interest of a director should be disclosed in this part.
Direct or indirect interest Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change 23 February 2023
No. of securities held prior to change 366,698 Fully Paid Ordinary Shares 400,000 Unlisted Options issued in Nov 2016 12,000,000 Unlisted Options issued in Aug 2020 61,216,767 Unlisted Options issued in Dec 2021
Class Unlisted Options
Number acquired 10,000,000 Unlisted Options
Number disposed 1,666,667 Unlisted Options
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation Nil
No. of securities held after change 366,698 Fully Paid Ordinary Shares 400,000 Unlisted Options issued in Nov 2016 12,000,000 Unlisted Options issued in Aug 2020 61,216,767 Unlisted Options issued in Dec 2021 8,333,333 Unlisted Options issued in Feb 2023
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Change of Director's Interest Notice
Part 2 Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of notifiable interest of a director should be disclosed in this part.
Detail of contract N/A
Nature of interest N/A
Name of registered holder (if issued securities) N/A
Date of change N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation N/A
Interest after change N/A
Part 3 +Closed period
Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? N/A
If so, was prior written clearance provided to allow the trade to proceed during this period? N/A
If prior written clearance was provided, on what date was this provided? N/A
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Change of Director's Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 3 01/01/2011

Frequently Asked Questions

What is the purpose of the Change of Director's Interest Notice?

It informs ASX about changes in a director's interests in securities.

Who is the director mentioned in the notice?

The director mentioned is Dr. Errol De Souza.

When was the last notice submitted?

The last notice was submitted on 28 November 2022.

What changes occurred on 23 February 2023?

On this date, Dr. De Souza acquired 10 million options and disposed of 1.67 million.

How many options does Dr. De Souza hold after the change?

After the change, he holds 8,333,333 unlisted options issued in February 2023.

Last updated: Feb 23, 2023